In vivo quantitative proton MRSI study of brain development from childhood to adolescence.

PubWeight™: 1.27‹?› | Rank: Top 10%

🔗 View Article (PMID 11836768)

Published in J Magn Reson Imaging on February 01, 2002

Authors

Alena Horská1, Walter E Kaufmann, Larry J Brant, Sakkubai Naidu, James C Harris, Peter B Barker

Author Affiliations

1: The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, School of Medicine, Baltimore, Maryland 21205, USA. ahorska@mri.jhu.edu

Articles citing this

Normal development of brain circuits. Neuropsychopharmacology (2010) 2.64

Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury. PLoS Med (2006) 1.91

Neuroimaging studies of normal brain development and their relevance for understanding childhood neuropsychiatric disorders. J Am Acad Child Adolesc Psychiatry (2008) 1.36

Long-term follow-up after gene therapy for canavan disease. Sci Transl Med (2012) 1.22

Regional apparent metabolite concentrations in young adult brain measured by (1)H MR spectroscopy at 3 Tesla. J Magn Reson Imaging (2008) 1.16

BOLD fMRI signal increases with age in selected brain regions in children. Neuroreport (2004) 1.05

In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism. Brain Res (2010) 1.03

Classification of childhood white matter disorders using proton MR spectroscopic imaging. AJNR Am J Neuroradiol (2008) 0.93

Neurochemical alterations in adolescent chronic marijuana smokers: a proton MRS study. Neuroimage (2011) 0.92

Metabolic markers of neuronal injury correlate with SIV CNS disease severity and inoculum in the macaque model of neuroAIDS. Magn Reson Med (2008) 0.91

Serial 1H-MRS in GM2 gangliosidoses. Eur J Pediatr (2007) 0.86

Reduced medial prefrontal N-acetyl-aspartate levels in pediatric major depressive disorder: a multi-voxel in vivo(1)H spectroscopy study. Psychiatry Res (2010) 0.84

Cerebral metabolite differences in adolescents with low birth weight: assessment with in vivo proton MR spectroscopy. Pediatr Radiol (2006) 0.84

Metabolic Alterations in Developing Brain After Injury: Knowns and Unknowns. Neurochem Res (2015) 0.83

Quantitative in vivo 1H spectroscopic imaging of metabolites in the early postnatal mouse brain at 17.6 T. MAGMA (2008) 0.82

Early metabolic development of posteromedial cortex and thalamus in humans analyzed via in vivo quantitative magnetic resonance spectroscopy. J Comp Neurol (2014) 0.80

Magnetic resonance spectroscopic imaging detects abnormalities in normal-appearing frontal lobe of patients with Sturge-Weber syndrome. J Neuroimaging (2008) 0.80

Fast 3D (1)H MRSI of the corticospinal tract in pediatric brain. J Magn Reson Imaging (2009) 0.79

Application of advanced neuroimaging modalities in pediatric traumatic brain injury. J Child Neurol (2014) 0.79

Assessing White Matter Microstructure in Brain Regions with Different Myelin Architecture Using MRI. PLoS One (2016) 0.78

Evaluation of disease progression in INCL by MR spectroscopy. Ann Clin Transl Neurol (2015) 0.78

Altered development of the dorsolateral prefrontal cortex in chromosome 22q11.2 deletion syndrome: an in vivo proton spectroscopy study. Biol Psychiatry (2012) 0.78

Assessment of disease severity in late infantile neuronal ceroid lipofuscinosis using multiparametric MR imaging. AJNR Am J Neuroradiol (2012) 0.77

Contributions of magnetic resonance spectroscopy to understanding development: potential applications in the study of adolescent alcohol use and abuse. Dev Psychopathol (2014) 0.76

Fragile X syndrome: a pilot proton magnetic resonance spectroscopy study in premutation carriers. J Neurodev Disord (2012) 0.76

A quantitative analysis of (1)H-MR spectroscopy at 3.0 T of three brain regions from childhood to middle age. Br J Radiol (2015) 0.75

Metabolic alterations in the anterior cingulate cortex and related cognitive deficits in late adolescent methamphetamine users. Addict Biol (2016) 0.75

Fronto-striatal glutamate in children with Tourette's disorder and attention-deficit/hyperactivity disorder. Neuroimage Clin (2016) 0.75

3T MR with diffusion tensor imaging and single-voxel spectroscopy in giant axonal neuropathy. J Magn Reson Imaging (2008) 0.75

Key concepts in MR spectroscopy and practical approaches to gaining biochemical information in children. Pediatr Radiol (2016) 0.75

Fronto-Striatal Glutamate in Autism Spectrum Disorder and Obsessive Compulsive Disorder. Neuropsychopharmacology (2016) 0.75

Maturational decrease of glutamate in the human cerebral cortex from childhood to young adulthood: A (1)H-MR spectroscopy study. Pediatr Res (2017) 0.75

Longitudinal increases of brain metabolite levels in 5-10 year old children. PLoS One (2017) 0.75

Articles by these authors

Accelerated longitudinal decline of aerobic capacity in healthy older adults. Circulation (2005) 4.61

Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation (2005) 4.19

Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol (2010) 4.03

Imaging cortical association tracts in the human brain using diffusion-tensor-based axonal tracking. Magn Reson Med (2002) 3.67

Multi-parametric neuroimaging reproducibility: a 3-T resource study. Neuroimage (2010) 3.32

Re-examining the brain regions crucial for orchestrating speech articulation. Brain (2004) 3.23

Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol (2008) 3.12

Advances in the treatment of fragile X syndrome. Pediatrics (2009) 3.10

Attenuated variants of Lesch-Nyhan disease. Brain (2010) 2.80

Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep. Neurology (2013) 2.79

Change in perfusion in acute nondominant hemisphere stroke may be better estimated by tests of hemispatial neglect than by the National Institutes of Health Stroke Scale. Stroke (2003) 2.61

Hierarchical linear modeling analyses of the NEO-PI-R scales in the Baltimore Longitudinal Study of Aging. Psychol Aging (2005) 2.56

Neuroanatomical assessment of biological maturity. Curr Biol (2012) 2.40

Delineation of the motor disorder of Lesch-Nyhan disease. Brain (2006) 2.30

Diffusion tensor imaging in children and adolescents: reproducibility, hemispheric, and age-related differences. Neuroimage (2006) 2.21

Rett syndrome and epilepsy: an update for child neurologists. Pediatr Neurol (2013) 2.17

Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol (2005) 2.16

Diffusion tensor imaging in schizophrenia. Biol Psychiatry (2005) 2.14

Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder. Biol Psychiatry (2002) 2.02

Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med (2009) 1.99

Spatial effects in the detection of gamma-aminobutyric acid: improved sensitivity at high fields using inner volume saturation. Magn Reson Med (2007) 1.91

Childhood obstructive sleep apnea associates with neuropsychological deficits and neuronal brain injury. PLoS Med (2006) 1.91

Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter. Ann Neurol (2002) 1.89

Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nat Genet (2012) 1.82

Anatomy of spatial attention: insights from perfusion imaging and hemispatial neglect in acute stroke. J Neurosci (2005) 1.75

Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome. J Neurosci (2010) 1.69

Effects of long-term diet restriction on aging and longevity in primates remain uncertain. J Gerontol A Biol Sci Med Sci (2004) 1.60

Restoring cerebral blood flow reveals neural regions critical for naming. J Neurosci (2006) 1.60

Mutations in POLR3A and POLR3B are a major cause of hypomyelinating leukodystrophies with or without dental abnormalities and/or hypogonadotropic hypogonadism. J Med Genet (2013) 1.59

Human brain hemorrhage: quantification of perihematoma edema by use of diffusion-weighted MR imaging. AJNR Am J Neuroradiol (2002) 1.59

Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome. J Med Genet (2014) 1.58

Acute intermittent porphyria: studies of the severe homozygous dominant disease provides insights into the neurologic attacks in acute porphyrias. Arch Neurol (2004) 1.58

Gannet: A batch-processing tool for the quantitative analysis of gamma-aminobutyric acid–edited MR spectroscopy spectra. J Magn Reson Imaging (2013) 1.57

Social behavior profile in young males with fragile X syndrome: characteristics and specificity. Am J Med Genet A (2004) 1.56

In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla. Magn Reson Med (2007) 1.55

Regional brain volume abnormalities in Lesch-Nyhan disease and its variants: a cross-sectional study. Lancet Neurol (2013) 1.55

Clinical proton MR spectroscopy in central nervous system disorders. Radiology (2014) 1.53

Subcortical brain atrophy persists even in HAART-regulated HIV disease. Brain Imaging Behav (2011) 1.53

Fast 3D chemical exchange saturation transfer (CEST) imaging of the human brain. Magn Reson Med (2010) 1.52

Multimodal imaging of the self-regulating developing brain. Proc Natl Acad Sci U S A (2012) 1.49

Serum erythropoietin and aging: a longitudinal analysis. J Am Geriatr Soc (2005) 1.45

Commentary from the DSM-5 Workgroup on Neurodevelopmental Disorders. J Am Acad Child Adolesc Psychiatry (2012) 1.45

Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS: correlation with [11C-methyl]thymidine PET and thallium-201 SPECT. Acad Radiol (2002) 1.43

Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement. J Magn Reson Imaging (2013) 1.43

Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging (2004) 1.40

Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome. Proc Natl Acad Sci U S A (2014) 1.40

Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res (2008) 1.36

Autism spectrum disorder in fragile X syndrome: a longitudinal evaluation. Am J Med Genet A (2009) 1.33

Macromolecule-suppressed GABA-edited magnetic resonance spectroscopy at 3T. Magn Reson Med (2012) 1.33

Imaging of brain tumors: MR spectroscopy and metabolic imaging. Neuroimaging Clin N Am (2010) 1.31

Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. Toxicol Sci (2006) 1.30

Behavioral aspects of Lesch-Nyhan disease and its variants. Dev Med Child Neurol (2005) 1.29

Adrenoleukodystrophy in female heterozygotes: underrecognized and undertreated. Mol Genet Metab (2011) 1.29

Model choice can obscure results in longitudinal studies. J Gerontol A Biol Sci Med Sci (2009) 1.28

In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Schizophr Bull (2012) 1.28

Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology (2011) 1.27

Measuring T2 in vivo with J-difference editing: application to GABA at 3 Tesla. J Magn Reson Imaging (2011) 1.24

Psychometric study of the Aberrant Behavior Checklist in Fragile X Syndrome and implications for targeted treatment. J Autism Dev Disord (2012) 1.23

Long-term influence of normal variation in neonatal characteristics on human brain development. Proc Natl Acad Sci U S A (2012) 1.23

Megalencephalic leukoencephalopathy with subcortical cysts. J Child Neurol (2003) 1.23

Longitudinal change in serum gamma-glutamyltransferase and cardiovascular disease mortality: a prospective population-based study in 76,113 Austrian adults. Arterioscler Thromb Vasc Biol (2008) 1.21

Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis: a case report and review of the literature. Am J Med Genet A (2008) 1.21

Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology (2002) 1.21

Olfactory biopsies demonstrate a defect in neuronal development in Rett's syndrome. Ann Neurol (2003) 1.19

Measuring cell-type specific differential methylation in human brain tissue. Genome Biol (2013) 1.19

Alterations in white matter pathways in Angelman syndrome. Dev Med Child Neurol (2010) 1.17

Trends in autism spectrum disorder diagnoses: 1994-2007. J Autism Dev Disord (2009) 1.17

A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia. J Magn Reson Imaging (2005) 1.17

Regional apparent metabolite concentrations in young adult brain measured by (1)H MR spectroscopy at 3 Tesla. J Magn Reson Imaging (2008) 1.16

Variability in subcortical aphasia is due to variable sites of cortical hypoperfusion. Brain Lang (2004) 1.15

Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study. Magn Reson Imaging (2010) 1.14

High resolution spectroscopic imaging of GABA at 3 Tesla. Magn Reson Med (2010) 1.13

Autism spectrum disorder in Fragile X syndrome: differential contribution of adaptive socialization and social withdrawal. Am J Med Genet A (2006) 1.13

The behavioral phenotype of FMR1 mutations. Am J Med Genet C Semin Med Genet (2010) 1.12

MRI parcellation of the frontal lobe in boys with attention deficit hyperactivity disorder or Tourette syndrome. Psychiatry Res (2002) 1.11

What can we learn about autism from studying fragile X syndrome? Dev Neurosci (2011) 1.11

Acceleration of 1H MR metabolic imaging with compressed sensing. Radiology (2013) 1.10

Impact of frequency drift on gamma-aminobutyric acid-edited MR spectroscopy. Magn Reson Med (2013) 1.10

Dynamic MR perfusion and proton MR spectroscopic imaging in Sturge-Weber syndrome: correlation with neurological symptoms. J Magn Reson Imaging (2006) 1.09

Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging (2005) 1.08

Stability of initial autism spectrum disorder diagnoses in community settings. J Autism Dev Disord (2011) 1.07

Benign and malignant breast lesions: diagnosis with multiparametric MR imaging. Radiology (2003) 1.07

Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation. BMC Neurosci (2010) 1.07

MR spectroscopy and spectroscopic imaging of the brain. Methods Mol Biol (2011) 1.07

White matter microstructural differences linked to left perisylvian language network in children with dyslexia. Cortex (2009) 1.07

Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels. Neuroimage (2013) 1.06

Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am J Neuroradiol (2003) 1.05

Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast. J Magn Reson Imaging (2009) 1.05

Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility. AJR Am J Roentgenol (2010) 1.05

Asymmetry and gender effect in functionally lateralized cortical regions: a proton MRS imaging study. J Magn Reson Imaging (2004) 1.04

Diffusion- and perfusion-weighted magnetic resonance imaging of the brain before and after coronary artery bypass grafting surgery. Stroke (2002) 1.04

Increased regional fractional anisotropy in highly screened attention-deficit hyperactivity disorder (ADHD). J Child Neurol (2011) 1.02

Optimized detection of lactate at high fields using inner volume saturation. Magn Reson Med (2006) 1.02

Changing the perspective on early development of Rett syndrome. Res Dev Disabil (2013) 1.02

Cerebral growth in Fragile X syndrome: review and comparison with Down syndrome. Microsc Res Tech (2002) 1.02

eIF2B-related disorders: antenatal onset and involvement of multiple organs. Am J Hum Genet (2003) 1.02

White matter alterations in deficit schizophrenia. Neuropsychopharmacology (2008) 1.02